Want to see HK:6078 full AI Analyst Report?
Top Page
Hygeia Healthcare Holdings Co., Ltd.
(6078)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$10.00
▼(-1.28% Downside)
Action:Reiterated
Date:08/29/26
The score is primarily held back by the pronounced 2025 profitability/ROE decline despite strong multi-year revenue growth and improving cash flow. Technically, the stock shows better near-term momentum but remains below the 200-day moving average, keeping the trend signal mixed. Valuation is a headwind given the ~31 P/E with no dividend yield provided.
Positive Factors
Strong Revenue Growth
Sustained multi-year revenue growth indicates expanding demand for the company’s hospital and medical services. A growing top line can support network expansion, improve operating scale, and strengthen the platform’s ability to build durable earnings over the next several quarters.
Negative Factors
Sharp Profitability Decline
The sharp fall in net margin materially weakens earnings quality and makes recent revenue growth less valuable to shareholders. If profitability does not recover, lower earnings capacity could constrain reinvestment, reduce returns, and make results less consistent over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained multi-year revenue growth indicates expanding demand for the company’s hospital and medical services. A growing top line can support network expansion, improve operating scale, and strengthen the platform’s ability to build durable earnings over the next several quarters.
Read all positive factors
Hygeia Healthcare Holdings Co., Ltd. (6078) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$5.84B
Dividend Yield0.39%
Average Volume (3M)1.03M
Price to Earnings (P/E)27.8
Beta (1Y)0.87
Revenue Growth1.59%
EPS Growth-58.55%
CountryHK
Employees8,026
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.29
Shares Outstanding618,499,000
10 Day Avg. Volume1,241,438
30 Day Avg. Volume1,028,350
Financial Highlights & Ratios
PEG Ratio-0.58
Price to Book (P/B)1.02
Price to Sales (P/S)1.72
P/FCF Ratio14.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$16.93Price Target Upside67.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.85
Revenue Forecast (FY)HK$4.16B
Hygeia Healthcare Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in compre...
How the Company Makes Money
Hygeia Healthcare Holdings generally makes money by delivering fee-based healthcare services through its hospitals and clinics. Key revenue streams typically include: (1) Inpatient services (e.g., hospital stays, surgeries, nursing care, use of op...
Hygeia Healthcare Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
70
Positive
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.98B | 4.01B | 4.45B | 4.08B | 3.20B | 2.32B |
| Gross Profit | 1.03B | 1.02B | 1.33B | 1.27B | 1.02B | 744.66M |
| EBITDA | 929.26M | 988.03M | 1.12B | 1.08B | 888.95M | 640.05M |
| Net Income | 174.87M | 164.53M | 598.26M | 682.93M | 476.78M | 441.46M |
Balance Sheet | ||||||
| Total Assets | 10.60B | 10.67B | 10.93B | 10.73B | 7.24B | 6.69B |
| Cash, Cash Equivalents and Short-Term Investments | 758.87M | 741.02M | 651.59M | 755.89M | 884.71M | 1.10B |
| Total Debt | 2.26B | 2.45B | 2.79B | 2.72B | 1.29B | 1.23B |
| Total Liabilities | 3.64B | 3.88B | 4.25B | 4.48B | 2.30B | 2.21B |
| Stockholders Equity | 6.94B | 6.77B | 6.65B | 6.23B | 4.93B | 4.46B |
Cash Flow | ||||||
| Free Cash Flow | 509.49M | 466.39M | 92.02M | -157.98M | 92.26M | -236.84M |
| Operating Cash Flow | 904.68M | 949.98M | 707.13M | 782.84M | 685.38M | 426.25M |
| Investing Cash Flow | -521.43M | -412.62M | -671.09M | -2.86B | -372.06M | -850.85M |
| Financing Cash Flow | -524.41M | -476.79M | -216.56M | 1.78B | -154.21M | 754.50M |
Hygeia Healthcare Holdings Co., Ltd. Technical Analysis
Negative
10.13
Price Trends
9.76
Negative
9.68
Negative
10.97
Negative
Market Momentum
-0.07
Negative
48.52
Neutral
70.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6078, the sentiment is Negative. The current price of 10.13 is above the 20-day moving average (MA) of 9.45, above the 50-day MA of 9.76, and below the 200-day MA of 10.97, indicating a neutral trend. The MACD of -0.07 indicates Negative momentum. The RSI at 48.52 is Neutral, neither overbought nor oversold. The STOCH value of 70.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6078.
Hygeia Healthcare Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$1.05B | 10.10 | 5.57% | 2.29% | 4.75% | ― | |
62 Neutral | HK$5.84B | 27.81 | 2.55% | 0.39% | 1.59% | -58.55% | |
54 Neutral | HK$6.11B | 26.75 | 1.87% | 1.84% | 6.52% | ― | |
52 Neutral | HK$1.10B | 78.10 | 0.48% | 1.10% | -3.26% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$1.03B | 31.06 | 1.27% | ― | ― | ― |
* Healthcare Sector Average
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
9.51
-3.89
-29.01%
HK:1951
Jinxin Fertility Group Ltd.
2.27
-0.16
-6.47%
HK:3309
C-MER Eye Care Holdings Limited
0.85
-0.91
-51.81%
HK:3886
Town Health International Medical Group Ltd.
0.16
-0.11
-40.07%
HK:6639
Arrail Group Ltd.
1.83
-0.09
-4.74%
Hygeia Healthcare Holdings Co., Ltd. Corporate Events
Hygeia Healthcare Lifts Profit, Boosts Cash Flow and Unveils Expanded Shareholder Return Plan
Aug 27, 2026
Hygeia Healthcare reported interim revenue of RMB1,961.0 million for the six months ended June 30, 2026, a slight 1.4% decline year-on-year, while net profit rose 4.7% to RMB257.4 million and gross margin expanded to 27.4%. Operating cash generati...
Hygeia Healthcare to Present 2026 Interim Results via Investor Call
Aug 27, 2026
Hygeia Healthcare Holdings Co., Ltd. has announced it will host a conference call on August 28, 2026, to present its interim financial results and discuss its business operations in detail. The presentation aims to give shareholders and potential ...
Hygeia Healthcare Sets Board Meeting to Approve Interim Results and Consider Dividend
Aug 12, 2026
Hygeia Healthcare Holdings Co., Ltd. has scheduled a board meeting for August 27, 2026 to review and approve the interim financial results for the six months ended June 30, 2026. The board will also consider the publication of these results and di...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.